Home / Recalls / Meitheal Pharmaceuticals, Inc / D-0108-2027

D-0108-2027 Class III Ongoing

Recalled by Meitheal Pharmaceuticals, Inc — Chicago, IL

FDA drug recall D-0108-2027 was initiated by Meitheal Pharmaceuticals, Inc on Oct 8, 2026 and is designated Class III. Reason for recall: Labeling: Label Lacks Warning or Rx Legend The recall status is ongoing. Affected quantity: 121,800 vials.

Recall Details

Product Type: Drugs
Report Date: Nov 4, 2026
Initiation Date: Oct 8, 2026
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 121,800 vials

Product Description

Vecuronium Bromide for Injection, 10mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL. NDC: 71288-744-11

Reason for Recall

Labeling: Label Lacks Warning or Rx Legend

Distribution Pattern

US. Nationwide

Code Information

Lot# T1P0213A: Exp. 30-Apr-29 Lot# T1P0313A: Exp. 30-Apr-29 Lot# T1P0412A: Exp. 30-Sep-28 Lot# T1P0413A: Exp. 30-Apr-29 Lot# T1P0512A: Exp. 30-Sep-28 Lot# T1P0513A: Exp. 30-Apr-29

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0108-2027
openFDA file date: Nov 10, 2026
Loaded by RegDataLab: Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Meitheal Pharmaceuticals, Inc

D-0109-2027 Class III — Vecuronium Bromide for Injection, 20mg, 10 Single-Dose Vials per carton… (Oct 8, 2026)
D-0340-2026 Class II — Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx… (Feb 9, 2026)
D-0801-2021 Class III — Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd… (Sep 3, 2021)
D-0286-2021 Class I — Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose… (Jan 27, 2021)